Skip to Content

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • ABI-007-MBC-001 tnAcity

    A Phase 2/3, Multicenter, Open-Label, Randomized Study of Weekly nabĀ®-Paclitaxel In Combination, Compared To Gemcitabine/Carboplatin, As First Line Negative (Triple Negative) Metastatic Breast Cancer

Showing trial 1 of 1

Also in this Section